Module 4 – April 2024, 8 – 12
Monday 8
Challenges in modelling CMT neuropathies | GianMaria Fabrizi Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona Verona, Italy |
New insights on motor nerve degeneration in CMT | Charlotte Sumner Neurology and Neuroscience Johns Hopkins University School of Medicine Baltimore, USA |
Next generation sequencing: applications in clinical practice and gene discovery | Stephan Zuchner University of Miami Miller School of Medicine Miami, USA |
Interactive session |
Tuesday 9
Axonal neuropathies: all the novelties on pathogenesis, clinical features and treatments | Mary Reilly Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK |
Demyelinating neuropathies: all the novelties on pathogenesis, clinical features and treatments | Davide Pareyson Department of Neurodegenerative and Rare Diseases, Milan, Italy |
HSAN: all the novelties on pathogenesis, clinical features and treatments | Matilde Laurà Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London London, UK |
Interactive session |
Wednesday 10
CANVAS | Andrea Cortese Department of Neuromuscular Diseases, UCL, Queen Square Institute of Neurology, London, UK |
Amyloid neuropathies | Laura Obici Amyloidosis Research and Treatment Centre, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy |
Thursday 11
Unfolded protein response targeting in CMT | Maurizio D’Antonio Biology of Myelin Unit, Division of Genetics and Cell Biology, Ospedale San Raffaele, Milano, Italy |
Gene therapies in CMT | Kleopas Kleopa The Cyprus Institute of Neurology and Genetics, Cyprus |
Spinal muscle atrophy | Lorenzo Maggi Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy |
Friday 12
Pediatric CMT | Isabella Moroni Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy |
Interactive sessions |